{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-045362","form_type":"8-K","ticker":"PAVM","cik":"0001624326","company_name":"PAVmed Inc.","filed_at":"2024-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.021964+00:00","generated_at":"2026-05-30T00:29:45.679611+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"PAVmed reports Q3 GAAP net income $64.3M driven by deconsolidation; Lucid EsoGuard revenue record $1.2M","bullets":["Lucid Q3 EsoGuard revenue $1.2M, a record; 2,787 commercial tests; October single-month record >1,400 tests.","GAAP net income $64.3M ($1.44 diluted EPS) largely due to Lucid deconsolidation; non-GAAP adjusted loss $5.4M ($0.54/share).","Cash and equivalents $0.8M as of Sept 30, 2024, down from $19.6M at Dec 31, 2023.","PAVmed deconsolidated Lucid on Sept 10; reached agreement to exchange $25M convertible debt for preferred equity to regain Nasdaq compliance; extension to Jan 31, 2025.","Veris completed pilot with Ohio State's James Cancer Hospital and awarded $1.8M NIH grant."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-045362","json":"https://secwatch.observer/filing/0001493152-24-045362.json","markdown":"https://secwatch.observer/filing/0001493152-24-045362.md","text":"https://secwatch.observer/filing/0001493152-24-045362.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1624326/000149315224045362/0001493152-24-045362-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1624326/000149315224045362/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T00:29:45.679611+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}